DiaMedica Therapeutics (DMAC) Non-cash Items (2017 - 2026)

DiaMedica Therapeutics has reported Non-cash Items for 10 years, with the latest figure at $16.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 377.99% year-over-year to $16.8 million; the trailing twelve-month figure through Mar 2026 stood at $16.8 million (up 377.99% YoY), and the FY2025 full-year result was $10.6 million, up 3.49% from the prior year.
• Non-cash Items for Q1 2026 stood at $16.8 million, up from $10.6 million in the prior quarter.
• The five-year high for Non-cash Items was $21.2 million in Q3 2025, with the low at $462000.0 in Q3 2023.
• Historically, Non-cash Items has averaged $6.1 million across 5 years, with a median of $3.7 million in 2023.
• Annual changes were most pronounced in 2022 — Non-cash Items soared 4794.12% — and 2024, when it slumped 72.15%.
• DiaMedica Therapeutics' Non-cash Items stood at $832000.0 in 2022, then changed by 0.0% to $832000.0 in 2023, then surged by 1131.13% to $10.2 million in 2024, then climbed by 3.49% to $10.6 million in 2025, then jumped by 58.59% to $16.8 million in 2026.
• The last three Non-cash Items figures came in at $16.8 million (Q1 2026), $10.6 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.